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ABSTRACT
Background: Hypertension is a dangerous condition that precedes many cardiovascular
events including myocardial infarction, stroke, transient cerebral ischemic attack and
symptomatic aortoiliac occlusive disease. While it is universally accepted that arteries
stiffen with age, the physiological reason for this is debated. In a previous study, by Dr.
Shana Roach Watson it was shown that collagen fibers re-orient themselves in a
circumferential direction, resulting in increased arterial stiffness. The study hypothesized
that this collagen remodeling could be a result of decreased nitric oxide production.
Methods: This study measured nitric oxide in two different ways, indirectly via
Immunoperoxidase staining for eNOS and directly via diaminofluorescein-2. In the
design there were two timepoints: 6 weeks and 6 months. Groups of mice (n=5) were
placed on either a high fat Western diet or a chow diet for 6 months. Young mice at 6
weeks of age on chow diet served as the baseline. For the immunoperoxidase staining
procedure, 6 µm sections were stained via immunohistochemistry. For the
diaminofluorescein-2 assay, the thoracic aorta (from the aortic arch to the diaphragm)
was cut longitudinally and pinned en face onto culture dishes with a 3-millimeter-thick
layer of black wax. They were stained with diaminofluorescein-2, and images were taken
with the In Vivo Imaging System (IVIS).
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Results: There was no significantt difference in endothelial Nitric Oxide Synthase
(eNOS) expression between the groups for the immunoperoxidase staining. There was
also no significant difference in Nitric Oxide release between the groups for the DAF-2
staining.
Conclusion: The lack of a significant decrease with age disproves our hypothesis that a
decline in nitric oxide is responsible for the re-orientation of collagen fibers in the arterial
wall.
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CHAPTER 1
INTRODUCTION
Arterial stiffness plays an important role in predicting major cardiovascular events
including myocardial infarction, stroke, transient cerebral ischemic attack and
symptomatic aortoiliac occlusive disease(Perticone et al., 2001a). According to the World
Health Organization, 17.9 million people die each year from cardiovascular events such
as these, an estimated 31% of all deaths worldwide. Arterial stiffness is defined as an
“artery’s ability to resist distension when a force is applied to it” (Greenwald, 2007).
While arterial stiffening occurs independently of atherosclerosis, it occurs in the same
context as atherosclerosis and diabetes and is a precursor for hypertension. Hypertension
can lead to heart failure due to the sustained increase in vascular load it imposes upon the
heart(Kamberi, Gorani, Hoxha, & Zahiti, 2013).
The amount of blood the heart can pump through the body is determined by the
pressure or load in the systemic circulation, known as the afterload (Ooi, Chung, & Biolo,
2008). Therefore, hypertension caused by arterial stiffness can severely impair cardiac
output. Arterial stiffness causes the systolic blood pressure to increase leading to an
upsurge in left ventricular workload and left ventricular hypertrophy (Agabiti-rosei &
Rizzoni, 2009; Ooi et al., 2008; Watabe & Hashimoto, 2006). Pulse wave velocity
(PWV) is a measure of arterial stiffness and a very good predictor of cardiovascular
mortality(Schiffrin, 2018) The left ventricle produces a pulse wave that travels through
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the arteries at a given velocity. There is a partial reflection of this forward wave that in
normal arteries returns to the aorta and augments the diastolic pressure(Greenwald, 2007;
Ooi et al., 2008). When arteries are stiff, the pulse wave is transmitted at a higher velocity
and the reflected wave augments systolic pressure instead of diastolic pressure resulting
in summation with the anterograde wave and increased peak pressure (see figure 1.1)
(Greenwald, 2007; Ooi et al., 2008). This phenomenon magnifies peripheral systolic
blood pressure and pulse pressure as well as worsening cardiac systolic performance and
efficiency.
It is universally accepted that arteries stiffen with age, but the physiological
reason for this is debated (see figure 1.2). Past theories have implicated altered
hemodynamics; however, the only known processes involved in arterial stiffening are
elastic fiber degradation, fibrosis, and medial calcification(Greenwald, 2007; Harvey,
Montezano, Lopes, Rios, & Touyz, 2016b, 2016a). Elastic fibers, one of the components
of the lamellar unit in the medial layer of the arterial wall, give the arterial wall its
elasticity. As aging occurs, elastic lamellae are broken down by proteolytic enzymes such
as serine and cysteine proteases as well as matrix metalloproteases, and then the elastin is
replaced with collagen which is 100-1000 times stiffer than elastin(Galis, 2002;
Greenwald, 2007; Jacob, 2003). Along with protease activity, fatigue failure can also
contribute to the fragmentation of elastin(Greenwald, 2007). The remaining elastin
undergoes calcification, reducing the pliability of the remaining elastic
lamellae(Greenwald, 2007). The reduced elastin content and the increased collagen
deposition (fibrosis) lead to arterial stiffening (Greenwald, 2007; Harvey et al., 2016b;
Intengan & Schiffrin 2001).
2

This study builds on a previous study by Shana Roach Watson on “Factors
Influencing the Collagen Fiber Angle Distribution in the Mouse Aorta.” Dr. Watson
hypothesized that changes in the active and passive forces in the arterial wall, related to
hypertension and arterial dysfunction, cause collagen fibers to re-orient themselves in a
circumferential direction, resulting in increased arterial stiffness (Watson, 2016). To test
this hypothesis, the 3D collagen fiber angle distribution was obtained from mice of
various genotypes (Apolipoprotein E (Apo E ) knockout (KO) vs. apoE MMP12 double
knockout), diet (chow diet vs Western diet), and age (6 weeks vs 6 months). To examine
the effects that hemodynamic forces have on vascular remodeling, the blood pressure and
blood velocity were measured and compared, along with the extracellular matrix
composition and the collagen fiber angle. It was also hypothesized that this type of
collagen remodeling could be a result of decreased nitric oxide production. To investigate
the role of nitric oxide production in collagen remodeling, endothelial nitric oxide
synthase expression was quantified via immunohistochemistry and then compared with
the previous results(Watson, 2016).
Dr. Watson’s results for endothelial nitric oxide synthase expression were
inconclusive, so we decided to repeat and expand upon the study by comparing two
different approaches to measuring nitric oxide production: indirect and direct (Watson,
2016). Measuring the nitric oxide levels in tissues is imperative for understanding its role
in physiological and pathological processes; however, because of its short lifespan (less
than 1 s), nitric oxide detection is difficult and complex (Blitterswijk et al., 1992).
Therefore, an indirect approach that quantifies the amount of endothelial nitric oxide
synthase (eNOS or NOS3), the enzyme in the endothelial cell that produces nitric oxide,
3

is often used to indicate potential for NO production. An alternative method is directly
measuring nitric oxide using DAF-2.
Specific Aim 1: To measure potential for nitric oxide production in the arterial
wall of mice according to age (6 week vs. 6 month) and diet (Western vs. chow). To
characterize the distribution of endothelial nitric oxide synthase expression as a marker of
endothelial dysfunction and to relate nitric oxide production to existing data on collagen
fiber angle.
Specific Aim 2: To directly measure nitric oxide production in the arterial wall of
mice according to age (6 week vs. 6 month) and diet (western vs. chow) using the DAF-2
method. To characterize the distribution of nitric oxide production as a marker of
endothelial dysfunction and to relate nitric oxide production to existing data on collagen
fiber angle.

4

Figure 1.1: Ageing of the Conduit Arteries: The thin grey line represents the
forward-going pressure wave while the dashed line represents the reflected
wave. The summation of these waves is represented by the thick black line.
Young mice have more compliant arteries so the PWV is slower and augments
diastolic pressure. Older mice have hypertensive arteries resulting in a fast
PWV which augments systolic pressure. Adapted from ‘Ageing of the Conduit
Arteries,’ by SE Greenwald, 2007, Journal of Pathology, 211, p. 157-172.
Copyright 2007 by the Pathological Society of Great Britain and Ireland.

Figure 1.2: Age and Pulse Pressure Amplification Pulse pressure waves in
patients 24,54 and 68 years of age. Adapted from ‘Vascular Stiffening and
Arterial Compliance’ by E. L. Schiffrin, 2004, American Journal of
Hypertension. p39-48. Copyright 2004 by the Canadian Institute of Health
Research Multidisciplinary Research Group.
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CHAPTER 2
BACKGROUND AND REVIEW OF LITERATURE
2.1 The Arterial Wall
To understand the process of vascular remodeling, it is first necessary to consider
the normal structure of the arterial wall. The vascular wall is composed of three layers;
the intima, the media and the adventitia (Gao, 2017; Jacob, 2003). The extracellular
matrix provides a structural framework for the cells of these three layers (see figure 2.1)
(Gao, 2017).
The tunica intima is the innermost layer of the blood vessel wall (Pugsley &
Tabrizchi, 2001). Endothelial cells, which play an important role in recruiting smooth
muscle cells to the vascular wall, sit on the basement membrane of the tunica intima
(Wagenseil, 2010). The basement membrane, or basal lamina, contains type IV collagen
and binds the endothelium to connective tissue (Jacob, 2003). The tunica intima plays a
crucial role in altering blood flow by releasing local chemicals called vasodilators which
can relax smooth muscle cells. The intima is separated from the media by a dense elastic
membrane called the internal elastic lamina (IEL) (Gao, 2017; Wagenseil, 2010). This
membrane is penetrated by pores where exchange of materials occurs between the
various layers. The fact that endothelial cells can also produce elastin suggests that they
might have contributed to the formation of the internal elastic lamina
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(Wagenseil., 2010). Vascular aging results in the migration of medial vascular smooth
muscle cells (VSMCs) across the IEL, causing the intima to thicken (Greenwald, 2007).
The media is the thickest layer of the vessel wall and is comprised of smooth
muscle cells, elastic fibers, collagen and ground substance in the form of a
mucopolysaccharide gel (Lesauskaite et al., 2001; Mark, 1981; Robert & Birembaut,
1989; Shadwick, 1999). Thick elastin bands form concentric elastic lamellae between the
smooth muscle cell layers, while finer elastin fibers form networks between these
lamellae (Gao, 2017). The elastin functions as an elastic reservoir that distributes stress
evenly onto the collagen fibers in the interstices which bind the tunica media to the inner
and outer tunics (Wagenseil, 2010). An elastic lamella and the smooth muscle cells
surrounding it is called a lamellar unit (Shadwick, 1999). In stress-free conditions the
collagen of the media displays a wavy pattern of fibers, while in a high stress state the
collagen fibers, elastic laminae and smooth muscle cells straighten to display a
circumferentially aligned pattern (Wagenseil, 2010). There is another dense elastic
membrane called the external elastic lamina that separates the media and the adventitia
which is made up of collagen fibers and fibroblasts (Gao, 2017).
The tunica externa or the adventitia is the outermost layer of the arterial wall and is
comprised primarily of fibro-elastic connective tissue (Pugsley & Tabrizchi, 2001). Vasa
vasorum, lymphatic vessels, nerves, fibroblasts, histological ground matrix, immune cells
and vascular progenitor cells are also found in the adventitia (Gao, 2017). The fibroblasts
produce the extracellular matrix as well as the matrix metalloproteinases. When exposed
to conditions that are less than ideal, these fibroblasts can release growth factors,
cytokines, chemokines and reactive oxygen species that alters the extracellular matrix
7

(Gao, 2017). The collagen fibers that comprise the adventitia are mainly Type I and are
arranged within the ground matrix so that they form a fibrous tissue (X. Liu, 1997).
Collagen and elastin are the main extracellular matrix components of the arterial
wall and the absolute and relative quantities of these proteins determine its biomechanical
properties (Jacob, 2003; Robert & Birembaut, 1989; J. E. Wagenseil & Mecham, 2013).
Matrix metalloproteinases (MMPs), such as collagenases and elastases, are capable of
degrading elastin and collagen. Between the ages of 20 and 90 years old, the intimamedia thickness of the human carotid artery increases two to threefold (Jacob, 2003).
Most of this increase in thickness is due to an increase in absolute collagen content. The
absolute elastin content stays the same while the relative elastin content significantly
decreases (Jacob, 2003). These changes result in the stiffening of the arteries. The arterial
compliance is determined by the ratio of elastin and collagen (Jacob, 2003).
2.2 Collagen
Collagen is the most abundant protein in mammals and is the main load carrying
element in the arterial walls (Fratzl, 2008; Gelse, Po, & Aigner, 2003). Collagens are
molecules found in the fibrillar and microfibrillar networks of the extracellular matrix
that are essential for maintaining structural integrity as well as for tissue assembly or
maintenance (Gelse et al., 2003). Collagen is a right-handed triple helix with a one
residue stagger comprised of three parallel polypeptide strands (α chains) in a lefthanded, polyproline II-type helical conformation coil ( Gelse et al., 2003). The three
chains are held together by inter-chain hydrogen bonds and electrostatic interactions.
Collagen has a singular amino acid composition, where proline and hydroxyproline
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account for 20% of the total and every third residue is glycine, following a Gly-X-Y
pattern (Gelse et al., 2003; Jacob, 2003; Robert & Birembaut, 1989). Contiguous to the
triple helical domains are non-Gly-X-Y regions abbreviated as NC for non-collagenous
(Gordon & Hahn, 2010). Since many different molecules contain Gly-X-Y triple helix
repetitions, the defining feature that makes a molecule collagen is somewhat subjective
(Gelse et al., 2003; Kadler, Baldock, Bella, & Raymond, 2007). Collagen can be a
heterotrimer or a homotrimer. A homotrimer has three identical alpha chains (collagens
II, III, VII, VIII, X) while a heterotrimer has at least one distinct alpha chain (collagens I,
IV, V, VI, IX, XI) (Gelse et al., 2003). To date, more than 20 types of collagen have been
discovered; however, the most common type of collagen is Type I (Fratzl, 2008; Gordon
& Hahn, 2010). Type I collagen is considered the exemplary collagen (Kadler et al.,
2007). It is heterotrimeric, triple helical, and has no imperfections or interruptions in the
triple helix, where imperfections are defined as one to three atypical residues in the triple
helix (Kadler et al., 2007).
The structure and function of collagens are very diverse. This diversity is a direct
result of having multiple α chains that can differ from one another, several molecular
isoforms, supramolecular structure and the use of alternative promoters and alternative
splicing (Ricard-blum, 2011). Because of this, collagens are divided into subfamilies
based on their supramolecular structure: fibril forming collagens, fibril-associated
collagen, network forming collagens, anchoring fibrils, transmembrane collagens and
basement membrane collagens (Gordon & Hahn, 2010).
Fibrillar collagens, the most abundant, are characterized by their torsional
stability and tensile strength making them excellent for structural purposes (Ricard-blum,
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2011). Because of the regular staggering of triple helical molecules, the fibril forming
collagens have a periodic structure. Fibrillar collagens are also the only collagens to have
a perfect Gly-X-Y triplet structure. All other collagens or non-fibrillar collagens have at
least one imperfection (Gordon & Hahn, 2010). Fibril forming collagens are synthesized
as procollagen, containing N and C propeptides at each end of the triple helical domain
until they are cleaved by proteinases in a process called fibrillogenesis. Type I collagen is
the most abundant fibril-forming collagen. It is also a heterotrimer which is unusual
because most collagens are homotrimers. Other fibril forming collagens include types II,
III, V, and XI (Gelse et al., 2003).
The best example of a microfibrillar collagen is Type VI collagen (Gelse et al.,
2003). This collagen is unusual because it has three distinct α chains (α1, α2, α3) which
have short triple helical regions and extended globular termini. Before being utilized in
the body, collagen VI undergoes extensive modification until it resembles tetramers
which are secreted into the extracellular matrix and form a vast microfibrillar network
that can be found in any connective tissue.
Type IV collagen is the prototypical network forming collagen and the most
important structural component of basement membranes (Mark, 1981; Robert &
Birembaut, 1989). Head to head interactions of two trimeric NC1 domains form
hexamers which make up a supramolecular network that incorporates laminins, nidogens
and other components (Gelse et al., 2003). This collagen forms chicken wire-like twodimensional structures that can be laterally associated to form three-dimensional
structures.
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Several types of collagen have been isolated in arteries including types I, III, IV,
V, and VI (Jacob, 2003; Robert & Birembaut, 1989; J. Wagenseil & Mecham, 2010). The
adventitia and media of the arterial wall are rich in interstitial collagens type I and III
(Robert & Birembaut, 1989). Type I tends to be near the surface of the smooth muscle
cells while type III tends to be closer to the elastic lamellae. These two types of collagen
are largely responsible for the tensile strength of vascular walls (Maurel et al., 1987).
Furthermore, age-related vascular dysfunction is characterized by abundant type I
collagen, produced by smooth muscle cells, migrating into the intima (Kohn, Lampi, &
Reinhart-King, 2015).
2.3 Atherosclerosis
Atherosclerosis is defined by marked narrowing of large elastic arteries due to the
buildup of plaque. Atherosclerosis can be divided into three stages: fatty streak, fibrous
plaque and complicated lesion. A fatty streak is an early lesion comprised of
subendothelial aggregations of cholesterol-laden macrophages also known as foam cells
(Insull, 2009). These early lesions are the body’s immune response to excess cholesterol
in the vessel wall. As low-density lipoprotein (“bad cholesterol”) accumulates in the
vessel wall, the body’s immune system sends macrophages to remove it; however, these
macrophages fail to remove the fatty deposits and instead become part of the plaque
(Insull, 2009; Jara, Medina, Vera-Lastra, & Amigo, 2006). Eventually, these fatty streaks
turn into fibrous plaques. Smooth muscle cells, macrophages, and lymphocytes form
plaques in the tunica intima of the blood vessel. The smooth muscle cells secrete
proteoglycans which bind lipids (Greaves & Gordon, 2001; Insull, 2009). These lipids
coalesce into pools contributing to cell death (Insull, 2009). The resulting cellular debris
11

forms a lipid-rich ‘necrotic core’ surrounded by a fibrous cap consisting of SMCs and a
proteoglycan-collagen matrix (Boon, Greenberg, Kitslaar, Tordoir, & Daemen, 2016;
Insull, 2009). With time, the fibrous cap can weaken and become susceptible to rupture.
When rupture does occur, it exposes the necrotic core to the bloodstream (Insull, 2009).
The body treats this as an injury and a blood clot forms, resulting in a complicated lesion.
If the blood clot grows sufficiently large or breaks off, it can occlude the artery, which
can cause a stroke or myocardial infarction.
Because wild type mice do not develop spontaneous atherosclerosis, we use
apolipoprotein E knockout mice(Tian, Li, Liu, Tong, & Zhang, 2016). Lipoproteins are
responsible for carrying cholesterol through the blood stream and are essential for
cholesterol clearance from the circulation (Arnold von Eckardstein, Jerzy-Roch Nofer,
2001). Apolipoprotein E is a major component of specific lipoproteins called very lowdensity lipoproteins (Arnold von Eckardstein, Jerzy-Roch Nofer, 2001; Tian et al., 2016).
A major function of VLDLs is to remove excess cholesterol from the blood and carry it to
the liver for processing (Arnold von Eckardstein, Jerzy-Roch Nofer, 2001). Without the
gene that codes for apolipoprotein E, mice will become susceptible to developing
spontaneous atherosclerosis (Tian et al., 2016).
2.4 Vascular Remodeling
The arterial wall is a dynamic structure that adapts to various stimuli by
rearranging its cellular and extracellular components, often to maintain adequate blood
flow and to regulate arterial wall stress (Rudic, 1998). This remodeling of the vessel wall
is usually a response to a long term change in hemodynamic conditions such as blood
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pressure and blood flow (Renna, Heras, & Miatello, 2013). Several types of structural
adaptations seen in vascular remodeling are shown schematically in figure 2.2. When
structural adaptations are based on changes in blood pressure, the diameter of the lumen
remains constant while the media to lumen ratio changes as shown in A and B in figure
2.2. When vascular remodeling structural adaptations are based on changes in blood flow,
the diameter of the lumen changes as seen in C and D in figure 2.2. E and F represent a
response to injury such as atherosclerotic lesion growth (Renna et al., 2013).
As stated above, one effect of vascular remodeling is to regulate arterial wall
stress. It has been theorized that when large arteries are in an exclusively hypertensive
state (have a high P), they undergo inward hypertrophic remodeling, thereby decreasing
the r/h ratio and maintaining the same arterial wall stress (see equation 1). This can be
seen in figure 2.2.
Vascular remodeling involves changes in at least four cellular processes: cell
growth, cell death, cell migration, and synthesis/degradation of the ECM. These
processes are influenced by local growth factors, vasoactive substances and
hemodynamic stimuli. During remodeling, smooth muscle cells proliferate and migrate
while synthesizing major components of the extracellular matrix such as proteoglycans
and collagen types I, III, IV and V, as well as MMPs and TIMPs (Ishikawa et al., 2000).
Matrix metalloproteinases degrade collagen types I, II, III, and IV and other extracellular
matrix molecules while TIMPs act as inhibitors of MMPs (Ishikawa et al., 2000).
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2.5 Mathematical Models of Vascular Growth and Remodeling
Vascular deformation can occur as a response to the active and passive forces
acting on the vessel wall. Noncontracting muscle and ECM deform passively in response
to hemodynamic forces, produce passive forces while vascular smooth muscle cells
produce active forces. These forces and the deformation that they cause can be
represented mathematically in various ways. One of these models is called a Mixture
Model, meaning that each load-bearing component of the arterial wall deforms in unity
with the rest of the wall but can occupy different states (stressed state vs. stress-free state)
(Gleason & Humphrey, 20004). This model is unlike its predecessor, the ‘kinematic
growth’ model put forward by Skalak, because it focuses on how remodeling occurs
rather than simply its consequences. The mixture model is an extension of a 2D model
that predicts arterial wall mechanics using the following equilibrium relations:

=

ℎ

,

=

ℎ(2 + ℎ)

(1)

Various studies suggest that a malfunction in vascular remodeling contributes to
hypertension as well as atherosclerosis (Sonoyama, Greenstein, Price, Khavandi, &
Heagerty, 2007). Human and animal subjects with hypertension experience heightened
peripheral vascular resistance due to impaired structural adaptation to high blood pressure
(Sonoyama et al., 2007). This is typically due to excess vasoconstriction that arises from
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a lack of endothelium dependent relaxation of the blood vessels. The corresponding
structural change is described as an increase in the cross-sectional area of the media
relative to the area of the lumen; this change can result from abnormal luminal
remodeling resulting in a narrower lumen, from an increase in wall thickness, or from a
decrease in external diameter of the vessel which is accompanied by a decrease in the
diameter of the lumen (Sonoyama et al., 2007). Nitric oxide, a vasodilator, has been
implicated by long term pharmacological studies as an important mediator which can
regulate wall to lumen ratios. These long-term pharmacological studies used inhibitors of
nitric oxide such as nitro-l-arginine methyl ester (L-NAME) to cause endothelial
dysfunction (defined as a lack of nitric oxide) and therefore increased hypertension
(Jacob, 2003).

2.6 Arterial stiffness and endothelial dysfunction as predictors of cardiovascular
events
In 2001, a study by Francesco Perticone and colleagues proved that forearm
endothelial dysfunction in hypertensive patients predicts cardiovascular events
demonstrating that research in endothelial dysfunction and hypertension has clinical
value. In this study, 225 patients with a history of hypertension were given 3 incremental
doses of acetylcholine, with each injection followed by measurement of the patient’s
forearm blood flow. The patients were observed over the course of their lives and
cardiovascular events were recorded. The patients that had the lowest percent increase in
forearm blood flow had the highest rate of cardiovascular events (Perticone et al., 2001b).
Perticone’s study was similar to Al Suwaidi’s 2000 study, except instead of
relating hypertension to endothelial dysfunction and cardiovascular events, Suwaidi
15

related endothelial dysfunction in general to cardiovascular events. 168 patients showing
symptoms of coronary atherosclerosis were selected. Coronary blood flow was calculated
after multiple infusions of acetylcholine. The participants were separated into 3 different
groups based upon their response to the acetylcholine. Results showed that the group that
had the lowest response to acetylcholine, had the highest rate of cardiovascular events
(Suwaidi et al., 2000).
In 2002, Blacher used pulse wave velocity (PWV), a linearized measure of arterial
stiffness, to predict mortality in end stage renal disease (ESRD) in a population of 241
patients undergoing hemodialysis. Patients had no history of cardiovascular disease and
had been on hemodialysis for at least 3 months. Transcutaneous Doppler flow recordings
were used to quantify aortic PWV. 469 subjects without ESRD were used to determine
multi-adjusted PWV cut-off values by constructing a nomogram.

Ninety-one deaths

were recorded, with 58 of those being cardiovascular-related. The patients with a positive
PW./V index had a two-fold increased risk of overall mortality (Blacher, Safar, Pannier,
Guerin, & Marchais, 2002). During this time, using increased wave reflection as an
indicator of vascular aging was not well-established. Wave reflection intensity was only
found to be an independent predictor of cardiovascular events in elderly patients with end
stage renal disease and following percutaneous coronary intervention. However, in March
2010 Kang-Ling Wang hypothesized that the usefulness of wave reflection intensity in
predicting cardiovascular events was underestimated since measures such as AI
(augmentation index) and Pa (augmented pressure) are affected by the reflected wave
transit time so instead he investigated time-independent measures of wave reflection.
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Kang-Ling Wang measured the carotid-femoral PWV using sequential
nondirectional Doppler flow velocity signals of 1272 normotensive and untreated
hypertensive Taiwanese subjects. Individual signals were subject to batch analysis and
five to ten waves were averaged to get a single wave. After a median of 15 years, 225
deaths had occurred with 64 of those deaths being cardiovascular. After the population
was stratified by age, PWV, Pa, and backward wave amplitudes (Pb) were predictive of
cardiovascular mortality (Wang, 2010).
2.7 Nitric Oxide and its Potential Role in Vascular Remodeling
Nitric oxide is a gaseous, free radical that plays a key role in signaling pathways
which modulate vascular tone, thrombogenicity and leukocyte-endothelium adhesion
(Blitterswijk et al., 1992; Kojima et al., 1998). Nitric oxide is referred to as an
endothelium-derived relaxing factor because it promotes smooth muscle relaxation which
dilates blood vessels (Massion, Feron, Dessy, & Balligand, 2003). Dilation (or
vasorelaxation) in turn raises blood supply and lowers blood pressure. This is
accomplished in a series of steps. First nitric oxide diffuses into the smooth muscle cells
surrounding small blood vessels and binds to guanylate cyclase, activating it (Manning,
2005). The activated guanylate cyclase then forms cyclic guanosine monophosphate (or
cGMP) by cleaving two phosphate groups from guanosine triphosphate (Manning, 2005).
cGMP phosphorylates proteins such as myosin, causing the cell to relax and the vessel to
dilate. Nitric oxide prevents thrombosis by inhibiting platelet aggregation and adhesion to
the vascular wall. It also decreases the expression of chemoattractant protein monocyte
chemoattractant protein 1, thereby preventing leucocyte adhesion to and migration into
the vascular wall and protecting the vascular wall against early phases of atherogenesis.
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NO protects against a later phase of atherogenesis by inhibiting the DNA synthesis,
mitogenesis, and proliferation of smooth muscle cells (Förstermann & Sessa, 2012).
NO is produced by three isoforms of nitric oxide synthase (NOS) found in various
cell types of the vascular wall. (V. W. T. Liu & Huang, 2008). Neuronal NOS is
expressed in endothelial and smooth muscle cells (Zhao et al., 2015). Inducible nitric
oxide synthase is also found in smooth muscle cells but its expression is reduced by
endothelial cells (Gonzalez-Fernandez et al., 1998). Endothelial nitric oxide synthase
(eNOS, NOS3) is found in the endothelial cells of the arterial wall.
This family of enzymes catalyzes the production of nitric oxide from L-arginine
(Förstermann & Sessa, 2012). These isoforms, (endothelial, neuronal, and inducible) are
encoded on separate chromosomes by separate genes (V. W. T. Liu & Huang, 2008).
They share homology in regions involved in cofactor binding and have similar enzymatic
mechanisms that involve electron transfer for oxidation of the terminal guanidine
nitrogen of L-arginine. All NOS proteins produce nitric oxide when flavins such as flavin
adenine dinucleotide and flavin mononucleotide transfer electrons from NADPH to the
heme in the amino terminal oxygenase base (Förstermann & Sessa, 2012). These
electrons are then used to reduce and activate oxygen and oxidize L-arginine to Lcitrulline and NO. This flow of electrons requires intracellular calcium (Zhao, Vanhoutte,
& Leung, 2015). An increase in calcium causes calmodulin affinity to NOS to increase
and this increase facilitates the flow of electrons from NADPH to the oxygenase domain.
Our study was primarily concerned with eNOS or endothelial nitric oxide
synthase. Besides calmodulin this enzyme can also be regulated by a range of other
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stimuli, the primary ones being fluid shear stress and pulsatile stretch. Often calmodulin
binding alone cannot result in NO production, because the enzyme is dependent on
protein phosphorylation and dephosphorylation (Förstermann & Sessa, 2012).
2.7.1 Endothelium Derived Relaxing Ractor is nitric oxide
Before 1980, it was known that acetylcholine caused vasodilation of arteries and
veins; however, the process by which this occurred was not fully understood until
Furchgott and Zawadzki’s realization that acetylcholine does not cause relaxation in the
absence of the endothelium. In their experiment, thoracic aortas were excised from
rabbits and 2.5 mm rings were cut. Some were prepared with special care to keep the
endothelium intact while the others underwent rubbing in order to remove the
endothelium. The thoracic aortas that had endothelial cells responded normally to
acetylcholine, while the other aortas had a lessened capacity to relax in the presence of
acetylcholine. This led to the theory of an endothelium-derived relaxing factor (EDRF).
To verify that this factor was coming from the endothelium and not the adventitial
surface, the adventitia was also rubbed off, but this had no effect on the relaxation
capacity of the aortic tissues (Zawadzki, 288AD).
In 1987, Louis Ignarro hypothesized that the endothelium-derived relaxing factor
discovered by Furchgott was actually nitric oxide. Ignaro mounted 3 portions of bovine
main pulmonary artery and vein one on top of the other and perfused them with
oxygenated Krebs bicarbonate solution. The strips were superfused with EDRF and NO
at different times, and the magnitudes and decrement of relaxation down the cascade of
strips were similar.
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Cyclic GMP levels, which were determined by monitoring the relaxation of the
strips and tone during quick freezing, were also comparable after being perfused with
calcium ionophore. The final experiment determining the chemical identification of
EDRF as NO, involved perfusing one of the three strips to delay relaxant responses. The
strips were perfused with either NO or perfusion media. An assay based on the
diazotization of sulfamic acid by NO was used to quantitate the NO released. The EDRF
was detected chemically as NO (Ignarro, Buga, Wood, & Byrns, 1987).
2.7.2 EDRF is released by endothelial nitric oxide synthase
In 1995, Paul Huang began to study the role of endothelial nitric oxide synthase in
vascular function by disrupting the gene encoding eNOS. Endothelial nitric oxide
synthase mutant mice were generated by homologous recombination. A Western blot
showed that eNOS was present in the wild type samples but not in the eNOS mutant
samples. The aortas were then dissected from the mice and mounted on tungsten wires in
conventional myographs after which they were exposed to increasing concentrations of
acetylcholine. The wild type mice responded with dose-dependent relaxation, while the
mutant type showed no relaxation. To determine blood pressure, mice were
anaesthetized with urethane or halothane and pressure recordings were taken. For awake
measurements a femoral artery catheter was used. The blood pressure for wild type mice
was 81, 90, and 97 mm Hg for urethane, halothane, and awake, respectively while the
blood pressure for mutant mice was 110, 109 and 117 for urethane, halothane, and awake,
respectively These experiments proved that mice lacking endothelial nitric oxide synthase
are hypertensive and lack EDRF activity, implicating endothelial nitric oxide synthase as
the source of EDRF (Huang, 2003).

20

2.7.3 Alternative techniques to measure nitric oxide
There are currently several techniques used to measure nitric oxide either directly
or indirectly. Each of these techniques has advantages and limitations often linked to their
sensitivity and specificity. It was the analysis of these methods that led to the search for a
more ideal approach to measuring nitric oxide.
Diaminonaphthalene assay
The diaminonaphthalene assay is a type of fluorometric determination that utilizes
the reaction of aromatic diamino compound 2,3-diaminoaphthalene with nitrous acid to
produce a highly fluorescent product known as 2,3-napthotriazole to be used as an
indicator of NO formation (Bryan & Grisham, 2008). The advantage of this assay is its
specificity, sensitivity, and versatility.
Diaminofluorescein-2 (DAF-2) may also be used to determine the presence of
nitric oxide. Nitrosation of the diamino group results in a nitrosamine, which through an
internal rearrangement forms the fluorescent triazole. DAFs contain a benzoic group
attached to a fluorophore. Fluorescein is widely used as a fluorophore because of its
convenient wavelengths, high extinction coefficient and high fluorescence quantum yield
in water. A potential problem with DAF-2 and its related compounds is that ascorbic acid
and dehydroascorbic acid can react with these probes and reduce their ability to detect
NO (Bryan & Grisham, 2008).
Colorimetric (Griess Reaction) Method
Because nitric oxide is so hard to measure, some methods focus entirely on
measuring the major metabolites of nitric oxide: nitrite and nitrate. The Griess reaction,
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described by Johann Peter Griess in 1879, involves the reaction between nitrite and
sulfanilic acid to form a diazonium cation which then couples to N-naphthylethylenediamine, forming a stable azo compound (See figure 2.4). (Griendling & Zweier,
2016; Sun et al., 2003). This purple product has an absorbance linearly proportional to
the nitrite concentration which can be measured by one of three methods:
spectrophotometry, fluorescence, or HPLC (Griendling & Zweier, 2016; Sun et al.,
2003). One advantage of using the Griess reaction is that these products are relatively
stable, unlike nitric oxide. The main drawback of the Griess Reaction for our purposes is
that it is typically used to quantitate nitric oxide in fluids, such as blood and urine, not in
endothelial tissue. Furthermore, the insensitivity of this method makes endotheliumderived nitrite difficult to quantitate.

Electrochemical Approaches
There are several electrochemical approaches to measuring nitric oxide; however,
they all involve microelectrodes coated so that they are selectively permeable to nitric
oxide (Griendling & Zweier, 2016). For example, in 1996 Tschudi and his team directly
measured nitric oxide with a porphyrinic microsensor in order to study the effects of
aging on NO release in isolated blood vessels. This porphryinic microsensor was used
previously by Malinski to measure nitric oxide in rat brain (Malinski, Bailey, Zhang, &
Chopp, 1993). This sensor was constructed by taking a pulled L-shaped glass capillary
and threading 5 to 10 carbon fibers through it so that 5 mm of the fibers were protruding
from the end. A copper wire was inserted into the opposite end of the capillary and then
sealed with conductive silver epoxy. The exposed carbon fibers were covered with a
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conductive polymeric film from a 0.25 mM solution of nickel (II) tetrakis porphyrin in
0.1 M NaOH under N2. It was placed in 1% Nafion solution in alcohol for fifteen seconds
and then allowed to dry. The porphryinic microsensor is advantageous because it is
highly sensitive, small in size and has a fast response time (this is ideal because NO has a
short half-life). Rats ranging from 5 months to 33 months old were sacrificed and their
aorta and pulmonary arteries were harvested. The arteries were cut into 5 mm rings, then
cut open longitudinally and pinned to the bottom of an organ chamber filled with HBSS
buffer. The microsensor was then used to measure nitric oxide. The drawbacks of this
sort of electrochemical detection are instability and low sensitivity of electrodes (Tschudi
et al., 1996).
Chemiluminescence
Chemiluminescence is a technique that can measure nitric oxide directly by its
reaction with ozone (Bryan & Grisham, 2008). When nitric oxide reacts with ozone, it
forms nitrogen dioxide in an excited state, which emits a photon that can be measured
upon decay to ground state; however, only 8% of the nitrogen dioxide is formed in the
excited state due to quenching. One solution to this problem is using modern
photomultiplier tubes. Photo multipliers contain cathodes inside a vacuum tube that cause
a photon to emit an electron due to the photoelectric effect. The photomultiplier tubes
then multiply this electron creating a shower of new electrons. This allows
chemiluminescence to measure NO in parts-per-billion.
Figure 2.5 is a basic diagram of a chemiluminescence apparatus which typically
includes a carrier gas (nitrogen), sample chamber, cold trap, and NO analyzer. The carrier
gas can be any gas that does not affect the NO measurements. Nitrogen is usually used
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due to high availability and low cost. The carrier gas bubbles through the liquid sample
removing the nitric oxide. The cold trap then prevents the sample and water vapor from
being suctioned into the NO analyzer. The NO analyzer draws a gaseous stream at rates
higher than 200 cc/min.
One major drawback of chemiluminescence is that it can only analyze nitric oxide
in its gas phase. It is difficult to extract gas-phase NO from thin tissue samples (such as
mouse aorta) without damaging the sample, especially with a gas flow rate higher than
200 cc/min. The nitric oxide level also has to be high enough to raise the photomultiplier
signal above the background level. However, chemiluminescence is excellent for large
samples with high amounts of nitric oxide.
Another drawback to chemiluminescence is its lack of selectivity.
Chemiluminescence measures any product that generates light upon reacting with ozone;
unfortunately, nitric oxide is not the only compound that does this.
Electron Paramagnetic Resonance and Spin Trapping
Unlike chemiluminescence, Electron Paramagnetic Resonance (EPR) is a specific and
sensitive indirect way of detecting nitric oxide (Liebert, 2004). Electron Paramagnetic
Resonance or EPR is a technique that identifies and quantifies free radicals by responding
to the transition of electron spins between energy levels; however, while nitric oxide is a
paramagnetic material, it is so short lived that spin trapping must be used (Xu, Gu, &
Qian, 2012). Spin traps react covalently with free radicals to form stable adducts in an
addition reaction with a nitrone or nitrose compound (Xu et al., 2012). There are various
spin traps for NO including hemoglobin, Fe complexes, and nitronyl nitroxides.
Hemoglobin is useful for measuring the nitric oxide in blood (Griendling & Zweier,
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2016). Iron-dithiocarbamate (Fe-DTC) spin traps are the most commonly used in ex vivo
NO detection (Liebert, 2004). In these experiments, organs are harvested and placed in an
EPR sample cell (tissue cell) before EPR signals are recorded (Liebert, 2004). Because
EPR NO spin trapping uses spectroscopy as opposed to colorimetry, it has the unique
capability of identifying the origin of the nitrogen and oxygen atoms that comprise nitric
oxide (Liebert, 2004). This showed that the source of nitrogen in nitric oxide was Larginine.
2.7.4 Using Diaminofluorescein to measure nitric oxide
Diaminofluorescein was first developed as a fluorescent indicator for nitric oxide
by Kojima and his team in 1998 (Kojima et al., 1998). They wanted to track the nitric
oxide production in a direct, real time fashion. Other methods had been developed, but
they lacked selectivity, sensitivity, and experimental practicality. They found that he
could utilize the reaction between nitric oxide and aromatic amines to produce triazenes.
They decided to combine the fluorescent properties of fluorescein with the reactive
properties of amine by using fluoresceinamine; however, the fluorescence was
diminished due to the electron donating group attached to the phthalic ring of fluorescein.
Because of this limitation, he designed and synthesized 4,5-diaminofluorescein or DAF2. To test this new indicator, the DAF-2 was applied to cultured rat aortic smooth muscle
cells and then imaged via a fluorescence microscope. The excitation and emission spectra
of DAF-2 were measured before and after the reaction with nitric oxide. The excitation
was measured at 495 nm while the emission was measured at 515 nm.
In 2003, Räthel and his team sought to measure miniscule levels of nitric oxide
more accurately by utilizing 4, 5-diaminofluoresceine to overcome the lack of specificity
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and sensitivity that pervades many other methods. Human endothelial cell lines were
used in the assays, and the fluorescent supernatants were measured and analyzed. The
DAF-2 was administered at different concentrations of 0.01 µM, 0.1 µM, 1 µM and 5 µM
before and after nitric oxide was released from endothelial cells. DAF-2’s ability to detect
nitric oxide increases as the concentration of DAF-2 decreases. To determine if
concentrations < 1 µM of DAF -2 detect all nitric oxide, They made two standard curves
with one comparing fluorescence intensity to increasing concentrations of DAF-2 and the
other to increasing concentrations of NO liberated from donor NOC-9. A major limitation
of this method is that it doesn’t enable measurement of nitric oxide directly on the tissue.
Another is that the sensitivity of the spectrofluorometer has to be fairly high (Räthel,
Leikert, Vollmar, & Dirsch, 2003).
2.7.5 Effect of age on kinetics of nitric oxide release in rat aorta
Several studies support the claim that nitric oxide production decreases with age.
The first is by Tschudi and his team, who used a porphyrinic NO microsensor to detect
nitric oxide release in young and old isolated rat aortas. After 10 umol/liter of calcium
ionophore was administered, the microsensor measured a higher release of nitric oxide in
young aorta than in old aorta (Tschudi et al., 1996).
Hongo and his team (1988) studied the effects of both aging and hypertension on
endothelium-dependent vascular relaxation in rat carotid artery. Four different types of
rats were used, young and old Wistar Kyoto (WKY) rats as well as young and old
spontaneously hypertensive rats (SHR). The common carotid artery was removed from
the rats and cut into 3 mm long rings. The resting tension was set at 2 grams, and 5hydroxytryptamine was used to induce contraction. Acetycholine was added, and the
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relaxation induced was calculated as a percentage of the contraction induced. The
percentages were as follows: 70.1for the young WKY, 45.6 in the old WKY, 35.1 in
young SHR and 21.4 in old SHR (Hongo et al., 1988).
In 1998, Chou and his team studied the decrease in expression of endothelial
nitric oxide synthase with aging and hypertension in rats. This was done by first
separating spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) into 4week, 14-week and 63-week time points. After removal of the aortas, NOS activity and
expression were measured by using L-citrulline formation and Western blot analysis,
respectively. While nitric oxide synthase activity went down somewhat with age in the
WKY rats (from 0.79 for the 4-week rats to 0.71 for the 63-week rats), eNOS expression
in the SHR went down much more dramatically (from 0.78 for the 4-week rats to 0.34 for
the 63-week rats). The Western blot analysis showed very similar results, with WKY and
SHR showing similar eNOS protein expression in the beginning, but with the SHR
decreasing significantly with age and WKY staying relatively constant (Chou, Yen, Li, &
Ding, 1998).
Another study on nitric oxide production was performed by Kevin Soucy (2006).
Soucy demonstrated the diminution of nitric oxide production with age using two
different techniques. He first did this by comparing the endothelium-dependent
vasorelaxation response in young and old aortas. To measure the vasodilation response,
aortic rings from both old and young rats were placed in 25 ml organ chambers and
suspended from a strain gauge. The vasorelaxation was calculated by percent decrease in
tension from the phenylephrine-induced preconstriction. The older aortas expressed less
vasorelaxation than the younger. While this did indicate that nitric oxide might be
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decreasing, it did not rule out other factors that can cause an endothelium-dependent
vasorelaxation response (Soucy et al., 2006).
Using fluorescence and a flow chamber system, Soucy was able to measure NO
production rates. The chamber system simulates the shear stress in the human body that
induces nitric oxide production. A monochromator-based spectrofluorometer and an
inverted fluorescence microscope measured lower nitric oxide production in the older
rats.
In 2010, Zanetti and her team, like Chou, also showed that endothelial nitric oxide
synthase protein decreases with age. Protein levels of eNOS as well as several other
proteins were measured using Western blot analysis. Results showed that eNOS
expression was markedly reduced (Zanetti et al., 2010).
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Figure 2.1: Structure of the arterial wall: Three layers comprise the
arterial wall: the tunica externa, the tunica media, and the tunica interna.
The tunica interna or the intima includes the lumen of the blood vessel
which is lined with endothelial cells. The tunica media is composed of
smooth muscle cells, while the tunica externa contains fibrous connective
tissue. Adopted from ‘Hyperelastic modelling of arterial layers with
distributed collagen fibre orientations’ by T. C. Gasser, 2006, Journal of
the Royal Society, 3, p, 15-35. Copyright 2005 by The Royal Society.
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Figure 2.2: Structural adaptations due to hypertension: In response to
increased blood pressure, the artery adapts by changing the media to
lumen ratio by changing the thickness of the vessel wall as seen in (A)and
(B). In response to changes in flow, the vessel adapts by changing the
dimensions of the lumen as seen in (C) and (D). Injury, such as an
atherosclerotic lesion, can result in either outward vessel remodeling or
occlusion as shown in (E) and (F). Adapted from ‘Pathophysiology of
Vascular Remodeling in Hyptertension’ by N. F. Renna, 2013,
International Journal of Hypertension, Copyright 2013 by the Hindawi
Publishing Corporation.
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Figure 2.3 Vascular remodeling due to hypertension: In response to
increased blood pressure, the artery adapts by changing the media to
lumen ratio by changing the thickness of the vessel wall. This is called
elastic distension. Endothelin 1, a vasoconstrictor increases as nitric oxide
decreases and the vessel vasoconstricts. This results in the remodeling of
the arterial wall. Adapted from ‘A Mixture Model of Arterial Growth and
Remodeling in Hypertension: Altered Muscle Tone and Tissue Turnover’
by R.L. Gleason & J.D. Humphrey, published by Journal of Vascular
Research, copryright 2004.
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Figure 2.4: Griess Reaction Assay: Nitrite is treated with a diazotizing
reagent such as sulfanilamide (SA) to form a diazonium salt. This salt then
reacts with N-naphthyl-ethylenediamine (NED) forming a stable azo
compound. The product releases an intense purple color with an
absorbance of 540 nm. Adapted from ‘Measurement of Nitric Oxide in
Biological Systems by Using Griess Reaction Assay’ by Jie Sun, 2003, p.
276–284.
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Figure 2.5: Setup of NO chemiluminescence instrument: NO related components are
reduced to NO gas and carried into NO analyzer. Cold trap, NaOH-filled trap, and filter
protect analyzer against humidity and acid vapors. In reaction chamber, NO gas is
combined with O3 from O2 tank. Signal is detected by photomultiplier tube and amplified.
Adapted from ‘Measuring Nitrite and Nitrate, Metabolites in the Nitric Oxide Pathway,
in Biological Materials using the Chemiluminescence Method.’ By Barbara Piknova,
2016, published by The Journal of Visualized Experiments, copyright 2016.
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CHAPTER 3
MATERIALS AND METHODS
3.1 INTRODUCTION
In this experimental design, there were two timepoints: 6 weeks and 6 months. However,
mice that are 6 months old have not aged enough to adequately mirror the vascular
dysfunction that normally occurs in elderly human patients. To rectify this shortcoming,
it was decided to place some of the mice on a Western diet for 6 months to cause them to
develop atherosclerosis and hence more closely mimic the endothelial dysfunction seen
in aging humans.
In this experiment groups of mice (n=5) were placed on either a high fat Western diet or a
chow diet for 6 months. Young mice at 6 weeks of age on chow diet served as the
baseline. The mice were sacrificed and the organs harvested. Samples of the aorta were
taken from the region of the fourth intercostal arteries and from the abdominal infrarenal
segment. These samples were placed in 4% paraformaldehyde (PFA), processed
overnight and embedded in paraffin. The blocks were then sectioned at a thickness of 6
µm.
3.2 Immunoperoxidase Staining Procedure
To deparaffinize the sections, the slides were placed in Histoclear twice for five
minutes and then once for three minutes. They were then placed in 100% ethanol three
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times for 30 seconds, in 95% ethanol twice for 30 seconds and once in 70% ethanol.
Finally, they were set in distilled water twice for thirty seconds.
After deparaffinization, the slides were washed for five minutes in 1X filtered PBS.
Then the endogenous peroxidase was blocked via a 5-minute incubation in 3% H2O2 at
room temperature. The slides were then washed twice for five minutes in 1X filtered PBS.
Antigen retrieval was performed using the citrate buffer technique. Citrate buffer
(pH 6.0) was preheated to 50-60 degrees C in a large beaker. The slides were placed in the
beaker and the buffer was heated to boiling for 10 minutes. Afterwards, the slides were
removed from the heat and allowed to cool for at least 10 minutes.
The slides were blocked with 10% goat serum in 1X PBS for 1 hour in a humid
chamber at room temperature. Rabbit anti-eNOS primary antibody was prepared in 10%
goat serum at 1:75 dilution. The slides were incubated for 2 hours with primary antibody.
The slides were washed twice for five minutes in 1X PBS and then incubated with
secondary antibody (biotin-labeled- goat anti-rabbit IgG at 1:100 dilution in 10% goat
serum) for 2 hours in a humid chamber at room temperature. The HRP-streptavidin
dilution was made with at a 1:250 ratio in 50 mM tris HCL (pH 7.2). After the secondary
antibody incubation, the slides were washed twice for five minutes in 1X filtered PBS.
The slides were incubated with HRP-streptavidin solution for 1 hour in a humid
chamber at room temperature. The excess solution was then discarded, and the slides were
washed two times for 5 minutes in 1X filtered PBS.

Meanwhile, a Vector DAB

(diaminobenzidine) substrate was made from a kit according to the manufacturer’s
instructions and protected from light. 100 µl of Vector DAB substrate was layered on the
positive control and watched under a microscope. The development time was determined
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using the positive control and this development time was applied to the rest of the slides in
batches of four. There were five different batches total. After development, each slide was
transferred to reagent-grade water.
Next the slides were stained for 1 minute and 30 seconds in hematoxylin, then
washed twice for 30 seconds in distilled water. They were dipped one time in 70% acid
alcohol and ten times in Scott’s solution. After this, they were washed for two minutes in
distilled water. The sections were then dehydrated. To dehydrate the slides, they were first
dipped ten times in 70% ethanol, ten times in 95% ethanol, and ten times in 100% ethanol.
They were then placed in Histoclear once for five minutes and once for three minutes.
Coverslips were mounted using Permount and allowed to dry before storing.
3.3 Immunofluorescence Staining Procedure
Immunoperoxidase and immunofluorescence staining procedures were compared
to achieve the best possible images for quantitation. For immunofluorescence,
deparaffinization was performed as described above for the immunoperoxidase staining
protocol.
After deparaffinizing, antigen retrieval was performed on the slides. The citrate
buffer (pH 6.0) was heated via hot plate to 60 C. The slides in the beaker were heated to
boiling for ten minutes. Afterwards, the slides were removed from the heat and allowed
to cool for at least ten minutes.
Next, the slides were blocked with 10% donkey serum in PBS for 1 hour in a
humid chamber at room temperature. The primary antibody (rabbit anti-eNOS antibody)
was diluted 1:75 in 10% donkey serum. After blocking, slides were incubated with
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primary antibody for 2 hours in a humid chamber at room temperature. The slides were
then washed twice for five minutes in PBS.
The secondary antibody was prepared in the dark at 1:100 Rhodamine Red X
(RRX) – donkey anti-rabbit IgG in 1X PBS. Slides were incubated in the dark with
secondary antibody for 2 hours. (All steps after this were completed in the dark.) The
slides were then rinsed twice for five minutes in 1 X PBS at room temperature. Hoechst
stock solution was centrifuged for 10 minutes at 1000 rpm before use. The slides were
counterstained for 5 min in 1: 10000 Hoechst 33258 in 1 X PBS at RT and rinsed twice
for 5 minutes in 1X PBS at room temperature. The slides were then rinsed briefly in
distilled water and coverslips were applied with 1-2 drops of Dako fluorescent mounting
medium.
3.4 Fluorescence Quantification
Fluorescent images were acquired using an Axiovision Imager.A1 microscope
(Zeiss) with an exposure time of 250 ms, a time weight of 28% and a digital gain of 8.
The brightness was -0.50, the contrast was 1.00 and the gamma setting was 1.50. Three
filters were used: DAPI, FITC and Rhodamine. Images taken with each filter were
merged in ImageJ software. Since the entire aortic cross section did not fit within the
field of view at 200X magnification, the samples were imaged by tiling, and the Kolor
Autopano software was used to stitch together images to visualize the complete cross
section. The red channel, containing the eNOS-specific staining, was extracted. The
aortic endothelium was manually traced using the polygon option in the ‘Measurements’
menu of ImageJ, to determine its area. To quantify area of positive staining for
endothelial nitric oxide synthase, a new ROI (region of interest) was created by tracing
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over the endothelium again. The intensity range was set to 76-255 for segmentation of
eNOS staining. The total segmented area was selected and summed up using the ‘count
objects’ function. The eNOS positive area was divided by the total endothelial area to
give percent eNOS expression.
3.5 DAF-2 Measurement with IVIS
This procedure is based on the published method of Ozaki. Pinning dishes were
prepared by coating the bottom of 60 x 15 mm tissue culture dishes with a ~3 millimeter
thick layer of black wax (Ozaki et al., 2002). Mice were sacrificed by carbon dioxide
asphyxiation and perfused for 5 min with heparinized saline to flush blood from the
circulation. The thoracic aorta (from the aortic arch to the diaphragm) was excised,
opened longitudinally, and mounted en face in a prepared pinning dish with stainless steel
insect pins (see figure 3.1).
The dissected aorta was placed temporarily in 5 ml PBS (pH 7.4) and refrigerated
until all specimens had been prepared (this was done within 8 hours). Once all the
arteries had been extracted, the PBS was replaced with 0.1 mol/l phosphate buffer (pH
7.4) containing 1.5 mmol/l calcium chloride. Each sample was placed in the IVIS with B
selected as the field of view. The samples were imaged with excitation at 465 nm and
emission at 520 nm with a high lamp level. After bringing the image into focus, three
pictures were taken: one with F2 medium binning, another with F2 small binning, and a
third with F1 small binning. The sample was removed from the IVIS and 50µl of DAF-2
DA was added to the dish to yield a final concentration of 10µmol/l. After a 5-minute
incubation, three new images were taken with the same settings as the previous three. 5
µl of 1 µmol/l acetylcholine was then added to the dish and the sample was incubated for
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an additional 5 minutes. A final set of three images was taken with the same settings as
the previous ones.
The result was three sets of images representing background fluorescence (no
DAF), unstimulated NO release, and ACh- stimulated NO release. The background
fluorescence was used as a negative control and was subtracted from the other two sets of
images during quantification. The second set of images only had the DAF-2 treatment
while acetylcholine, which stimulates nitric oxide release, was applied to the specimen in
the third set.
3.6 IVIS
To image the thoracic aortas with DAF-2, we used the IVIS Spectrum (In Vivo Imaging
System manufactured by PerkinElmer).
Binning
Pixel binning is a procedure that combines a cluster of pixels into a single pixel in
order to reduce noise, and to improve the signal-to-noise ratio and frame rate. For
example in 3x3 binning, 9 pixels would become 1. While this does result in a loss of
information, binning data also reduces read noise on the processed image. The IVIS has
three different settings for binning – Low, Medium and High, with low binning providing
the highest resolution (but longer processing time) and high binning providing the lowest
resolution (but shortest processing time).
Field of View
The IVIS spectrum has a static camera and therefore the field of view is changed by a
stage that moves up and down. The IVIS spectrum has 5 preset heights for the stage
designated as A through E, with A being closest to the camera and therefore having the
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smallest field of view and E being the farthest away and therefore having the largest field
of view.
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Figure 3.1: Depiction of the aortic tree denoting the dissection
procedure. Adopted from ‘Aorta Atherosclerosis Lesion Analysis
in Hyperlipidemic Mice’ by Changjun Yin, 2016, bio protoc
journal, copyright 2016, published by PubMed Central

Figure 3.2 Schematic of an In Vivo Imaging System (IVIS): adapted
from ‘Pre-clinical In-vivo Imaging’ by Tamara Troy, published by
PerkinElmer, 2014.
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CHAPTER 4
RESULTS
4.1 Immunoperoxidase Staining
Figure 4.1 shows representative immunoperoxidase staining of aortic tissue
segments from chow diet-fed and Western diet-fed mice varying in age from 6 weeks to 6
months. Panels A – C show the immunoperoxidase staining of aortic tissue segments
taken from the abdominal aorta while Panels D- F show the immunoperoxidase staining
of aortic tissue segments taken from the level of the fourth intercostal arteries. Panel G is
the negative control. The development time was 1 minute and 30 seconds.
Figure 4.2 provides a bar graph illustrating the average percent eNOS expression
in the intima for each mouse experimental group. The average eNOS % expression for
intercostal 6 week chow, 6 month chow, and 6 month Western Diet in the intercostal
segment was 15.3 ± 5.7, 13.26 ± 9.99, 24.45 ± 22.65, respectively. The average eNOS
% expression for abdominal 6 week chow, 6 month chow, and 6 month Western diet was
abdominal segment 18.93 ± 9.05, 9.08 ± 4.41, 12.00 ± 19.28. There was no significant
difference between these measurements when conducting an ANOVA test.
4.2 Immunofluorescence Staining
Immunofluorescent staining was performed on chow diet-fed and Western dietfed mice varying in age from 6 weeks to 6 months. These segments were taken from the
abdominal aorta as well as from the thoracic aorta at the level of the fourth intercostal
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arteries. The fluorescent staining did not work as well as the immunoperoxidase staining
due to nonspecific staining in the media, so the data was not used.
4.3 DAF -2 Staining
Figure 4.4 provides a bar graph illustrating the average percent NO release for
each experimental group, measured as integrated fluorescence intensity over the tissue
area. To determine the NO release in the samples, the negative control value was used as
a baseline and subtracted from the integrated intensity values in the DAF-2 and
acetylcholine-treated samples. Integrated fluorescence intensity values were separated by
tissue treatment (DAF-2 alone vs DAF-2 plus acetylcholine) as well as by mouse age and
diet. As shown in figure 4.5, acetylcholine treatment induced an increase in DAF-2
fluorescence for all experimental groups, as expected.
Figure 4.5 provides a bar graph illustrating the average percent NO release for the
experimental groups divided by age only.
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Figure 4.1: Immunoperoxidase Staining: Immunoperoxidase staining of arterial
sections of ApoE knockout mice taken from the abdominal aorta at (A) 6 weeks and (B-C)
6 months. (A-B) Chow diet. (C) Western diet. Immunoperoxidase staining of aortic
sections of ApoE knockout mice taken from the level of the fourth intercostal arteries at
(D) 6 weeks and (E-F) 6 months. (D-E) Chow diet. (F) Western diet. G is the negative
control.
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Figure 4.2: Mean Immunoperoxidase Data: Mean endothelial nitric oxide synthase
expression in ApoE knockout mice obtained via immunoperoxidase staining at 6 weeks or
after 6 months on diet for the three treatment groups. No significant differences between
treatment groups were observed.
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Figure 4.3: DAF-2 Staining: DAF-2 staining of longitudinally cut thoracic arteries of
ApoE knockout mice. (A,D&G) are controls, (B,E,&H) contained DAF-2 only, and
(C,F,&I) contained both DAF-2 and acetylcholine. A-C were 6 weeks and D – I were 6
months. A-F were placed on a Chow Diet while D-I were placed on a Western Diet.
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Figure 4.4: DAF-2 Nitric Oxide Expression Data: Nitric Oxide
expression in ApoE knockout mice obtained via DAF-2 at 6
weeks or after 6 months. Measurements were taken after the
administration of Acetylcholine. A single factor ANOVA test was
conducted and no significant difference was found.
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Figure 4.5: DAF-2 Nitric Oxide Expression Data by Age: Mean
nitric oxide expression in ApoE knockout mice obtained via DAF- at
6 weeks or after 6 months on diet for the three treatment groups. A
significant difference was found using a two-sample t-test assuming
unequal variances.
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Chapter 5
Discussion
5.1 Introduction
In her dissertation, “Factors Influencing the Collagen Fiber Angle Distribution in
The Mouse Aorta,” Dr. Shana Watson used second-harmonic generation microscopy to
demonstrate that collagen fiber angle changes with age. What she did not determine was
the cause of the collagen remodeling. The first hypothesis tested was that changes in
hemodynamics were driving collagen fiber reorganization; however, no differences with
age were found in physiological variables such as blood pressure and blood flow velocity.
Therefore, it was hypothesized that a decrease in nitric oxide was responsible for the
collagen fiber angle change. The purpose of this study was to determine if the changes in
collagen fiber angle with age were related to decreased nitric oxide production in the
arterial wall. This was done by measuring nitric oxide both directly and indirectly in mice
with ages, diet, and genotype identical to the mice used in the previous experiments.
5.2: Aim 1
Measuring protein expression via Immunoperoxidase staining demonstrated that
for ApoE knockout mice, between the age of 6 weeks and 6 months, there is no
significant difference in endothelial nitric oxide synthase expression with age or diet. The
methods used produced a high level of variability. This is most likely due to the fact that
samples consisted of thin slices of the aorta rather than measuring the protein expression
48

of the entire aorta. These results were very unexpected because most of the studies
described in the literature have shown that endothelial nitric oxide synthase decreases
with age; however, it does nothing to disprove our hypothesis that a decrease in nitric
oxide is responsible for changes in collagen fiber angle. This experiment (for Specific
Aim I) detected eNOS protein expression, not activity. While endothelial nitric oxide
synthase protein expression remained the same, its activity might have gone down. The
regulation of eNOS activity is a complex process that involves more than just temporary
rises in intracellular calcium concentration. It also involves fatty-acid modifications,
caveolin, availability of arginine, cofactors such as BH4, and phosphorylation at Ser 1179
and Thr 497 (Huang, 2003). There are two types of fatty acid modifications that alter
eNOS activity: myristoylation and palmitoylation. Both fatty acid modifications are
crucial for eNOS to generate nitric oxide. Myristoylation, a process necessary for eNOS
to become membrane-associated, occurs when an aminopeptidase exposes the glycine at
the N terminus of eNOS. When the glycine has been mutated, myristoylation does not
occur resulting in a soluble protein that produces significantly less nitric oxide
(Udenwobele et al., 2017). Palmitoylation is also required for the proper localization of
eNOS to the membrane, specifically to domains called caveolae (Huang, 2003).
Furthermore, other factors, such as the amount of superoxide formation in vessels, can
also influence the bioavailability of nitric oxide even if nitric oxide synthase activity is
high (Huang, 2003). If nitric oxide reacts with a superoxide anion to form peroxynitrite
anion it is impossible for the nitric oxide to regulate vascular tone.
Smith and colleagues showed that the phosphorylation of eNOS significantly
decreases with age (Smith, Visioli, Frei, & Hagen, 2006). Their study measured the
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acetylcholine-induced relaxation of both young and old mouse aorta and determined that
relaxation was significantly reduced for the older mice (Smith et al., 2006). Western blot
analysis was then used to show that there was no reduction of eNOS protein levels with
age (Smith et al., 2006). The endothelia of rat aortas were subjected to Western blot using
antibodies to specific phosphorylation sites of the eNOS protein to determine whether the
protein had undergone phosphorylation. Results revealed that eNOS showed reduced
phosphorylation (a decline of 71%) at the S1176 site with age. This study showed that
while eNOS protein expression can stay the same, nitric oxide bioavailability can
decrease with loss of phosphorylation.
There have also been studies that have noted an increase in eNOS expression with
age such as Donato’s study (Donato et al., 2009). The study first notes that healthy
endothelium-dependent dilation is impaired in adult humans but then admits that the
reason for this is unclear. The authors go on to recognize that nitric oxide is the “most
important vasodilatory molecule synthesized by the endothelium”. Hence, the purpose of
this study was to determine if endothelial nitric oxide synthase is responsible for changes
in NO production. However, unlike our study which used mice, the study by Donato, et
al. used human subjects. Endothelial cells were collected by advancing J-wires into the
brachial artery and then withdrawing them. The cells collected were transferred to slides
and stained. The authors observed that both eNOS and its phosphorylated isoform
increased with age.
These results contradict those described in most of the literature on nitric oxide
synthase expression with age. In the study by Smith and colleagues, the differences in
results could arise from a sampling issue. Their study had less than 10 mice for each
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category, whereas other studies used at least 100 rats (Chou et al., 1998). Donato’s study
also included a relatively small of number of subjects. They used 56 healthy,18-78 year
old males (less than 30 for each category) (Donato et al., 2009). If these men are healthy
at 78 years of age, they probably ate right and exercised, both of which raise nitric oxide
levels. Donato’s study is different from the current work since he used humans instead of
mice; however, this is significant because the whole point of testing mice is to infer what
is happening in the human vasculature. Most of the studies that found decreased
endothelial nitric oxide synthase with age used rats, not mice. This could mean that mice,
for this one experiment, represent what is happening in the human vasculature more
accurately than rats.
Because there is evidence that nitric oxide bioavailability does not necessarily
correspond to nitric oxide synthase expression, the only way to determine if nitric oxide
is responsible for changes in collagen fiber angle is to measure it directly.
5.3 Aim 2
Directly measuring nitric oxide via DAF-2 demonstrated that, for ApoE knockout
mice between the ages of 6 weeks and 6 months, there is no statistical difference in basal
or acetylcholine-stimulated nitric oxide levels with age or diet. These results corroborate
our nitric oxide synthase protein expression findings. However, when divided solely by
age there was a significant increase. This is probably due to the fact that with age the
arteries enlarge, and nitric oxide increases with blood flow. While these results seem to
contradict the literature, most of the literature that showed nitric oxide expression
decreasing with age did not use mice that were only 6 months old which may be too
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young to show vascular dysfunction. They started with mice that were a lot older or they
used rats that were a lot older. So, while it may remain true that at a certain age, nitric
oxide begins to decrease, these findings do not support the hypothesis that a decrease in
nitric oxide production is responsible for the collagen remodeling seen in previous
experiments.
Many factors besides nitric oxide play a role in establishing the basal arterial tone.
An alternative cause of collagen remodeling could be changes in the production of
bradykinins, which cause cycloxygenase (found in the endothelium) to release
prostacyclin – an effective vasodilator (Kirkby et al., 2012). Like nitric oxide,
prostacyclin also inhibits platelet activation, helping to prevent atherosclerosis and
endothelial dysfunction. Nitric oxide and prostacyclin are considered the most important
cardioprotective paracrine factors. Prostacyclin synthesis begins when phospholipase A2
releases arachidonic acid from membrane bound lipids (Mitchell, Ali, Bailey, Moreno, &
Harrington, 2008). The arachidonic acid is metabolized by cyclooxygenase form
prostaglandin H2, which is the substrate for downstream enzymes that eventually form
prostacyclin. After being released by the endothelial cells, prostacyclin binds to cell
surface receptors and activates the enzyme adenylate cyclase, which converts ATP to
cAMP, which causing relaxation of the blood vessels. Like nitric oxide, prostacyclin
release is dependent on intracellular calcium levels (Mitchell et al., 2008). Also, like
nitric oxide, there have been studies showing that prostacyclin decreases with age. For
example, in 1991, Tokunaga tested endothelial cells of human aortas for prostacyclin.
Aortic tissues were obtained within 2 hours after death and were embedded in paraffin.
They were then sectioned, and stable 6-keto PGF1α was measured with a
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radioimmunoassay kit. While Tokunaga found prostacyclin in all the subjects, the
intensity of the prostacyclin expression was lower in the older subjects (Tokunaga,
Yamada, Fan, & Watanabe, 1991).
Other possible factors that may alter basal arterial tone include vasoconstrictors
such as thromboxane. Thromboxane has effects opposite to those of prostacyclin. While
prostacyclin inhibits platelet activation, causes vessels to dilate, and reduces vascular
smooth muscle cell remodeling, thromboxane increases platelet activation, causes vessels
to constrict, and induces smooth muscle cell proliferation. Usually thromboxane and
prostacyclin maintain a certain balance when the body is in homeostasis. However,
sometimes they are out of balance, resulting in endothelial dysfunction. This can result
from either a shortage of prostacyclin or an excess of thromboxane.
5.4: Limitations of the study
There were several limitations of this study. Most of the studies that found a
decrease in nitric oxide with age used rats rather than mice and compared nitric oxide
levels at ages much greater than 6 months. For example, Chou used 141 rats up to 63
weeks old. Likewise, Tschudi used rats ranging from 6 months old to 33 months old. In
Hongo’s experiment, rats were also used, at ages ranging from 14 weeks to 11 months.
While Soucy used both rats and mice, his mice were almost a year old (twice the age of
our own).
Another limitation is exclusive to the immunoperoxidase quantitation. Each
arterial tissue section is only 6 µm in thickness; thus, even within a given region, the
sections are not acquired from the same location. The small sample size of a single
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arterial cross-section gives a poor representation of nitric oxide synthase expression in the
entire artery. This is where the direct measurement of nitric oxide using DAF-2 becomes
advantageous. Unlike immunofluorescence, our method using DAF-2 measured nitric
oxide expression of the entire thoracic aorta. However, the DAF-2 method we used had
its own limitation. Since nitric oxide release depends on the enzymatic activity of nitric
oxide synthase, measuring nitric oxide using DAF-2 must be done rapidly after the tissue
is harvested, since activity will diminish over time.
5.5: Further Research
To overcome some of these limitations, further research is needed. First, this
experiment should be redone with a larger population of mice It should also be done over
a greater age range, similar to those investigated in published studies. The ages would
include 6 weeks (young), 6 months (middle aged), and 1 year (old). The 6 months and 1
year would also be separated according to diet (Western vs. chow). I predict that nitric
oxide expression will start to resemble a bell curve rather than a linear progression. To
eliminate the tissue sampling issues with immunofluorescence imaging, multiple sections
can be taken from the tissue and averaged. Another option is to use en face fluorescent
staining which involves staining the entire thoracic artery.
However, since both the DAF-2 assay and immunoperoxidase staining show
consistent results, it is reasonable to conclude that the results are accurate and not a
sampling issue. So, if changes in nitric oxide production are not the cause of collagen
remodeling, it might be that basal arterial tone is altered by imbalances in another
vasodilator (e.g., prostacyclin) or a vasoconstrictor such as bradykinin. The best way to
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determine whether basal arterial tone changes with age is to do myography to measure
the basal tone of the arteries directly.
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Chapter 6
Conclusion
Our data indicates that there was no significant difference in endothelial Nitric Oxide
Synthase (eNOS) expression between the groups for the immunoperoxidase staining.
There was also no significant difference in Nitric Oxide release between the groups for
the DAF-2 staining. The lack of a significant decrease with age disproves our hypothesis
that a decline in nitric oxide is responsible for the re-orientation of collagen fibers in the
arterial wall.
An alternative cause of collagen remodeling could be changes in the production of
bradykinins and thromboxane. Usually thromboxane and prostacyclin maintain a certain
balance when the body is in homeostasis. However, sometimes they are out of balance,
resulting in endothelial dysfunction. This can result from either a shortage of prostacyclin
or an excess of thromboxane. The best way to determine whether basal arterial tone
changes with age is to do myography to measure the basal tone of the arteries directly.
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